Available from our 503A patient specific pharmacy.
Click here to download the product insert.
Free overnight shipping for orders greater than $750.
| Classification | Delayed Release Capsule |
|---|---|
| Strength (Concentration) common dose* | 150mg |
| Size (Volume) | Capsule |
*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. ImprimisRx® dispenses only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.
Potential Ingredient Risks
Storage: Store at Room Temperature 20°C to 25°C (68°F to 77°F).
Auxiliary Labeling: Keep all medicine out of the reach of children and pets. Throw away any unused medicine after the beyond use date. Do not flush unused medications or pour down a sink or drain
PPS-DR (pentosan polysulfate sodium delayed release) Capsule
Possible Indications: Symptomatic relief of bladder pain or discomfort associated with interstitial cystitis
Possible Adverse Effects: Rectal hemorrhage and bleeding Thrombocytopenia Alopecia
Potential Contraindications/Precautions: Safety and efficacy of pentosan polysulfate sodium in pediatric patients younger than 16 years of age have not been established. Pentosan polysulfate sodium should be used with caution in patients with hepatic impairment. The drug has not been evaluated in this patient population. Because pentosan polysulfate sodium undergoes hepatic metabolism, hepatic impairment might alter the pharmacokinetics of the drug. It is not known whether pentosan polysulfate sodium is distributed into milk the drug should be used with caution in nursing women.